Androgenetic Alopecia Treatment: Associating 1550nm Erbium-Glass Laser with Drug Injections of Active Principles

The study evaluated the effectiveness of combining 1550nm Erbium Glass laser therapy with drug injections (minoxidil, finasteride, growth factors, and vitamin complex) for treating androgenetic alopecia in 62 patients. The treatment involved monthly sessions, ranging from 3 to 14 per patient. Results showed that 48.39% of patients experienced slight improvement, while 46.77% had significant improvement. A high satisfaction rate of 96.77% was reported, with those undergoing more than six sessions being particularly satisfied. The study concluded that this combined approach was an effective and safe treatment option for androgenetic alopecia.